Shire buys into regenerative medicine with Pervasis purchase

Article Date: 13/04/2012 10:00
Shire buys into regenerative medicine with Pervasis purchase

Vacancy Search

Quick job search

Advanced Search

Latest News

Wales approves Celgene's Imnovid despite NICE 'no'

Wales approves Celgene's Imnovid despite NICE 'no'

Comms Team entry deadline approaching

Comms Team entry deadline approaching

Exciting sponsorship opportunities at INTCR 2016

Exciting sponsorship opportunities at INTCR 2016

Exelixis' melanoma combo bags first global approval

Exelixis' melanoma combo bags first global approval

FDA green light for Amgen's PCSK9 inhibitor Repatha

FDA green light for Amgen's PCSK9 inhibitor Repatha

GSK signs up QB3 to seek out new collaborations

GSK signs up QB3 to seek out new collaborations

Novo snaps up two US biotechs

Novo snaps up two US biotechs

US nod for BI/Lilly's diabetes combo pill

US nod for BI/Lilly's diabetes combo pill

Allied-Bristol licenses Yale tech for new cancer approach

Allied-Bristol licenses Yale tech for new cancer approach

GSK/Lilly pulmonary hypertension combo continues to impress

GSK/Lilly pulmonary hypertension combo continues to impress
more news